MassMutual Private Wealth & Trust, FSB
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1103653
Windsor, CT
Position in PTGX
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$16,057
+$2,882 QoQ
Shares Held
131
+4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#293
of 341 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MassMutual Private Wealth & Trust, FSB holds $21,953,680 across 115 Biotechnology names. PTGX ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,385 | $14,099,681 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,576 | $5,971,019 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
10,629 | $414,637 | |
| 4 | INCY |
Incyte Corp
|
1,311 | $148,614 | |
| 5 | MRNA |
Moderna, Inc.
|
1,817 | $127,244 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,697 | $92,333 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,396 | $78,273 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
283 | $68,194 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,057 | 131 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $13,175 | 125 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $10,393 | 119 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $7,905 | 119 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $6,577 | 119 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,176 | 45 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $1,968 | 51 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $135 | 3 | Shares | Sole | 2024-10-02 | |
| No filing history on record for this holder in this stock. | ||||||